Chokri Ben Lamine: No Routine VTE Prophylaxis for Chronically Bedridden Patients at Home
Chokri Ben Lamine, Adult Hematology and SCT Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared a post on X:
“Short answer (guideline-based):
No routine VTE prophylaxis for chronically bedridden patients at home.
Guideline Position
American College of Chest Physicians (CHEST Guidelines)
Do NOT recommend pharmacologic prophylaxis for:
- Chronically immobilized patients
- Nursing home residents
- Home-bound patients without acute illness
Rationale:
- Lower VTE incidence vs hospitalized patients
- Higher bleeding risk outweighs benefit
American Society of Hematology (ASH 2018/2021 VTE Guidelines)
Suggest against routine prophylaxis in:
- Long-term immobile patients at home
- Unless additional strong transient risk factors present
When to consider prophylaxis (exception cases)
Only if high-risk transient state, e.g.:
- Recent hospitalization (≤45–90 days)
- Active cancer (especially + chemo)
- Prior VTE
- Acute infection/inflammation
- Marked reduced mobility with additional risk (improve score high)
In such cases short-term prophylaxis may be considered (case-by-case)
Extended prophylaxis trials (important nuance)
- MAGELLAN trial
- APEX trial
- MARINER trial
Show benefit in selected high-risk recently hospitalized patients, not applicable to stable chronically bedridden home patients
Practical Hematology Take
Bedridden alone isn’t indication
Always balance:
VTE risk vs bleeding risk
Focus on:
- Hydration
- Mobilization if possible
- Reassess if clinical status changes
Key References
- Kahn SR et al. CHEST Guideline (2012, updated concepts)
- Spyropoulos AC et al., MARINER Trial (NEJM 2018)
- Cohen AT et al., MAGELLAN Trial (NEJM 2013)
One-line clinical answer
No routine pharmacologic VTE prophylaxis for chronically bedridden patients at home unless additional high-risk transient factors are present.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration